All News #Library
Rare Diseases
SN BioScience Gains FDA Orphan Drug Status for SNB-101
24 Dec 2025 //
PR NEWSWIRE
EMA Grants SN Bio`s SNB-101 Orphan Drug Status For SCLC
31 May 2024 //
PR NEWSWIRE
SN Bio received FDA Orphan Drug Designation for Nano Anti-Cancer Drug `SNB-101`
29 Feb 2024 //
PR NEWSWIRE

Market Place
Sourcing Support